-
-
-
-
-
-
-
Evogene and ELEO team up on oral PCSK9 inhibitor discovery
-
-
-
-
-
-
-
Evogene (EVGN) Misses Q4 EPS by 20c
-
-
-
-
-
-
-
Evogene (EVGN) Tops Q3 EPS by 12c
-
-
-
-
-
-
-
Evogene (EVGN) Tops Q4 EPS by 66c
-
-
-
-
-
-
-
Form SC 13G/A Evogene Ltd. Filed by: ARK Investment Management LLC
-
486,196 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


